LIQUID OR AEROSOLIZED COMPOSITION COMPRISING A LUNG SURFACTANT POLYPEPTIDE AND AT LEAST ONE INHIBITOR OF A MEDIATOR OF TISSUE DESTRUCTION AND SUCH A COMPOSITION FOR PULMONARY DELIVERY

摘要

The invention provides compositions and methods for treating pulmonary conditions and for reducing the negative effects of pulmonary inflammation. Such compositions and methods employ protease inhibitors and a lung surfactant mixture. The compositions and methods can also include lipase inhibitors (e.g. a phospholipase inhibitors) and anti-oxidants.